Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2021-06-30 Major Shareholding Noti…
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, volumes, and methods (e.g., '장내매도' - on-market sale). This falls under the category of Major Shareholding Notification.
2021-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the changes in share ownership by a major shareholder (Kim Jun-hyung) of the company 'Mujin Medi'. In the provided classification schema, reports detailing personal share transactions by company directors and executives (insider trades) are classified as 'Director's Dealing' (DIRS).
2021-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This document details the acquisition of shares by an executive (Park Hyun-il) of the company 'Moogene Medi'. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it tracks insider transactions and changes in ownership by company directors/executives.
2021-05-20 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by the company 'Mujin Medi'. It details the patent name, content, and utilization plan. Since this is a regulatory announcement of a corporate event (patent acquisition) that does not fit into specific financial reporting categories like 10-K, IR, or M&A, it falls under the general regulatory filing category.
2021-05-13 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the results of an Investor Relations (IR) meeting held by the company. It provides details on the date, location, participants, and agenda of the meeting, and confirms that the IR materials have been posted to the Korea Exchange's disclosure system. According to the 'Menu vs Meal' rule, since this is a brief announcement regarding the occurrence of an event and the availability of materials rather than the presentation itself, it is classified as a Report Publication Announcement (RPA).
2021-05-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the changes in share ownership by Aion Investment Management in the company Mujin Medi. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant changes in share ownership levels.
2021-05-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.